---
title: "Tesamorelin: What It Is, Evidence and Legal Status (2026)"
description: "Tesamorelin: growth-hormone-releasing peptide approved for one use. FDA-approved use. US status as of Oct 17, 2026: approved, one use. No dosing, no…"
canonical: https://plainlygraded.com/peptides/tesamorelin/
last_updated: 2026-10-17
breadcrumb: "Home > Compounds > Tesamorelin"
publisher: Plainly Graded
policy: "No dosing, no sourcing, no vendor links. Every claim cites a public source."
---

> We collect and compare information from public, cited sources. We cannot guarantee that it is complete, current or correct. This is not medical advice. Only a doctor can prescribe, and a doctor should confirm anything you read here before you act on it.

# Tesamorelin

Also called "Egrifta"

- [FDA approved, one use](https://plainlygraded.com/regulatory/#tesamorelin)
- [WADA S2 · prohibited at all times](https://plainlygraded.com/regulatory/#tesamorelin)

STATUS AS OF 17 OCT 2026

FDA: approved as Egrifta for excess abdominal fat in HIV-associated lipodystrophy only · WADA: prohibited at all times under the 2026 WADA List (S2.2.4, growth hormone releasing factors) · [tracker entry](https://plainlygraded.com/regulatory/#tesamorelin)

**The short answer:** Tesamorelin is a lab-made version of growth-hormone-releasing hormone. As of October 17, 2026 it is FDA-approved for one use only, reducing excess belly fat in people with HIV-associated lipodystrophy, and it is prohibited in sport at all times under the 2026 WADA List.

Written by [Maren Holt](https://plainlygraded.com/about/team/)

2 PUBLIC SOURCES · UPDATED 17 OCT 2026 · NO TIES TO SELLERS

[How we source](https://plainlygraded.com/how-we-source/)

## What is Tesamorelin?

Growth-hormone-releasing peptide approved for one use. Full section still to be written.

## What is Tesamorelin claimed to do, and what does the evidence show?

**Overall grade**

- Approved

**Strongest evidence**

Randomized trials

| Use | Claimed | Shown | Grade |
| --- | --- | --- | --- |
| Abdominal fat in HIV-associated lipodystrophy | Reduces belly fat | Approved by the FDA for this use only. Other uses marketed online have not been approved.[1] | Approved |

## What are the known risks and side effects of Tesamorelin?

The approved label lists the known side effects and warnings. We link to it rather than restate it.

Who should be especially careful

-   **People who are pregnant, trying to get pregnant or breastfeeding.** There is no human data in pregnancy.
-   **Anyone under 18.** It has not been studied in young people.
-   **Tested athletes and service members.** Check with USADA or your service's rules first. A positive test counts whatever the label said.
-   **People taking prescription medicines.** Interactions have not been studied. Bring the product label to your clinician.

Get medical help now if you have

-   Swelling of the face, lips or throat, trouble breathing, chest pain, a racing heart or fainting. **Call 911.**
-   Redness spreading from an injection site, warmth, pus or a fever. Get same-day care.
-   Unsure what you took or whether a reaction is serious: **Poison Control 1-800-222-1222** (free, 24 hours).
-   Thoughts of harming yourself: call or text **988**.

## Is Tesamorelin legal?

Approved as Egrifta for excess abdominal fat in HIV-associated lipodystrophy only.[1]

Every status change for Tesamorelin is logged with its date and source in the [regulatory tracker entry for Tesamorelin](https://plainlygraded.com/regulatory/#tesamorelin).

## Is Tesamorelin banned in sport?

Prohibited at all times under the 2026 WADA List (S2.2.4, growth hormone releasing factors).[2] Anti-doping rules work on strict liability: a positive test counts whatever the label said.

## What don't we know about Tesamorelin?

Still unknown

-   Effects in the off-label uses it is marketed for online.

Why this page has no dosing

We don't publish doses, schedules or mixing instructions for Tesamorelin or any unapproved peptide. No human dose has been established for most of these uses, so we list what to ask a licensed prescriber instead.

 [Here's why, and who can legally answer](https://plainlygraded.com/why-we-dont-give-dosing/)

## What should you tell your doctor if you're using Tesamorelin?

Tell them exactly what you took, for how long, and where it came from, and bring the label. These questions can help the conversation:

-   Is there an approved treatment for my goal that has been tested in people?
-   What should I watch for, and which symptoms mean I should stop and call you?
-   Could it interact with the medicines I already take?

### Compare next

- [Sermorelin](https://plainlygraded.com/peptides/sermorelin/)

**Sources**

1.  DailyMed / US Food and Drug Administration. Egrifta (tesamorelin) prescribing information.
2.  World Anti-Doping Agency. [2026 Prohibited List (sections S0 and S2)](https://www.wada-ama.org/en/prohibited-list), 2026-01-01.

**Changelog**

17 OCT 2026 Draft. Statuses read from the regulatory record dated 2026-10-17.

Spotted an error? [Report it](https://plainlygraded.com/corrections/). We never change a page's updated date without changing its content.

---

We collect and compare information from public, cited sources. We cannot guarantee that it is complete, current or correct. This is not medical advice. Only a doctor can prescribe, and a doctor should confirm anything you read here before you act on it.

Canonical page: https://plainlygraded.com/peptides/tesamorelin/
